Beone Medicines Ltd. Class A · SSE:688235
Lee Chan Henry sold 428 Beone Medicines Ltd. Class A shares (Form 4)
Traded Jun 11, 2026 · Filed Jun 15, 2026
On Jun 11, 2026, Lee Chan Henry (SVP, General Counsel) sold 428 Beone Medicines Ltd. Class A shares at US$257.64 for US$110K, leaving 0 shares. Filed Jun 15, 2026 (Form 4).
- Sold
- 428 shares
- Price
- US$257.64
- Value
- US$110K
- Holding after
- 0 shares
- Trading plan
- No
- Role
- SVP, General Counsel
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Ordinary Shares | Award | 45,071 | 346,554 | Direct | |
| Jun 11, 2026 | American Depositary Shares | Sale | 428 | US$257.64 | 0 | Direct |
Source
Related
- Beone Medicines Ltd. Class A
- Lee Chan Henry
- Beone Medicines Ltd. Class A shareholders
- Form 4 · Lee Chan Henry · Oct 2, 2026
- Form 4 · Lee Chan Henry · Aug 13, 2026
- Form 4 · Lee Chan Henry · Aug 3, 2026
- Form 4 · Lee Chan Henry · Jul 24, 2026
- Form 4 · Lee Chan Henry · Jul 10, 2026
- Form 4 · Wang Xiaodong · Oct 15, 2026
- Form 4 · Wang Xiaodong · Sep 30, 2026
- Form 4 · Baker Bros. Advisors LP · Sep 16, 2026
- Schedule 13D/A · Baker Bros. Advisors LP · Sep 16, 2026
- Form 4 · Wang Xiaodong · Sep 10, 2026